Neovasc Inc. (NVCN)
(Delayed Data from NSDQ)
$0.50 USD
+0.01 (2.96%)
Updated May 3, 2019 03:59 PM ET
After-Market: $0.49 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.50 USD
+0.01 (2.96%)
Updated May 3, 2019 03:59 PM ET
After-Market: $0.49 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Becton, Dickinson (BDX) Q2 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Becton, Dickinson and Company (BDX), popularly known as BD, reported second-quarter fiscal 2017 earnings of $2.30 per share, which beat the Zacks Consensus Estimate of $2.23 and increased 5.5% on a year-over-year basis.
Will Neovasc (NVCN) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Neovasc Inc (NVCN).
Neovasc (NVCN) Catches Eye: Stock Adds 27.1% in Session
by Zacks Equity Research
Neovasc Inc. (NVCN) moved big last session, as its shares jumped a little over 27% on the day.
Boston Scientific Acquires Neovasc to Boost Heart Business
by Zacks Equity Research
Boston Scientific Corporation (BSX) recently completed the acquisition of specialty medical device company Neovasc Inc.'s (NVCN) tissue processing technology.